postmarketing adverse drug reaction reports for amoxapine , maprotiline hydrochloride , and trazodone hydrochloride and premarketing adverse drug reaction data for bupropion hydrochloride and nomifensine maleate are reviewed , and the role of the new agents in the management of depressive illness is discussed .
C0282369
trazodone hydrochloride
C0011581
depressive illness